RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
(Unlearned) lessons from John Graunt and Kenneth Rothman: A “CLASSic” example
Arellano, FM., & Castellsague, J. (2003). (Unlearned) lessons from John Graunt and Kenneth Rothman: A “CLASSic” example. Clinical Therapeutics, 25(11), 2891-2896. https://doi.org/10.1016/S0149-2918(03)80341-7
This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Lonngterm Arthritis Safety Study